Adam Rogers
Direttore/Membro del Consiglio presso NERVGEN PHARMA CORP.
Patrimonio netto: 15 000 $ in data 30/04/2024
Profilo
Dr. Adam Rogers, MD, is a Chief Executive Officer at Hemera Biosciences, Inc. He is on the Board of Directors at NervGen Pharma Corp.
and One Family, Inc. Dr. Rogers was previously employed as a Member by Emory University School of Medicine.
He received his undergraduate degree from Emory University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NERVGEN PHARMA CORP.
0.02% | 23/05/2023 | 10 000 ( 0.02% ) | 15 000 $ | 30/04/2024 |
Posizioni attive di Adam Rogers
| Società | Posizione | Inizio |
|---|---|---|
| NERVGEN PHARMA CORP. | Direttore/Membro del Consiglio | 14/07/2022 |
Hemera Biosciences, Inc.
 Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Amministratore Delegato | 01/01/2017 |
| One Family, Inc. | Direttore/Membro del Consiglio | 01/01/2007 |
Precedenti posizioni note di Adam Rogers
| Società | Posizione | Fine |
|---|---|---|
| Emory University School of Medicine | Corporate Officer/Principal | 02/01/1991 |
Formazione di Adam Rogers
| Emory University School of Medicine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NERVGEN PHARMA CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
Hemera Biosciences, Inc.
Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Health Technology |
| One Family, Inc. |
- Borsa valori
- Insiders
- Adam Rogers
